Research inventory
| Personal data | Research themes | Ongoing teaching | Publications |

Laboratory of Experimental Neurology
Person in charge of the Unit : Oui
1. Study of the genetic predisposition to epilepsy and to antieplieptic treatment response (pharmacogenetics).2.Investigations on the pathogenesis of Friedreich ataxia and development of new cellular and animal models.3. Development of the induced pluripotent stem cell (iPS) technology for nervous system disease modeling (epilepsy, ataxia). 4. Mechanisms of frataxin gene silencing in Friedreich ataxia and development of therapeutic approaches to restore frataxin gene expression. 5. Investigations on cerebellar physiology and biochemistry by combining microdialysis and neurophysiological recordings on animal models (rodents).
Investigations on the pathogenesis of Friedreich ataxia and development of new animal models.
Analysis of frataxin function and of changes in cellular homeostasis resulting from frataxin deficiency. Utilization of siRNA to generate cellular and animal models of Friedreich ataxia.
Setup of technology to reprogram differentiated cells (fibroblasts) for control individuals and fro individuals with neurological diseases to generate pluripotent stem cells (iPS). Molecular and physiological characterization of iPS cell-derived neurons and glial cells to establish cellular models of neurological diseases. iPS cell grafts into animal models of neurological diseases as experimental therapies.
Genetic association, gene expression and proteomics studies to investigate the genetic basis of predisposition to epilepsys and to treatment response.
Chromatin and DNA binding proteins analysis in the frataxin gene in the presence of the Friedreich ataxia mutation (GAA expansion) and reactivation of gene expression by using designed DNA ligands and histone deacetylase inhibitors.